---
document_datetime: 2025-11-23 07:09:04
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/arepanrix.html
document_name: arepanrix.html
version: success
processing_time: 0.1029752
conversion_datetime: 2025-12-25 06:19:16.378896
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Arepanrix

[RSS](/en/individual-human-medicine.xml/66086)

##### Withdrawn

This medicine's authorisation has been withdrawn

pandemic influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted)

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Arepanrix](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On the 23 March 2010 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Arepanrix, pandemic influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted), which had been approved for prophylaxis of influenza in an officially declared pandemic situation.

The marketing authorisation holder (MAH) responsible for Arepanrix was GlaxoSmithKline Biologicals S.A. The European Commission was notified by a letter dated 22 November 2010 of the MAH's decision to voluntarily withdraw the marketing authorisation as of the Commission Decision date for Arepanrix for commercial reasons. Arepanrix was not marketed in any European country.

On 13 December 2010 the European Commission issued a decision to withdraw the marketing authorisation for Arepanrix. Pursuant to this decision the European Public Assessment Report for Arepanrix is updated to reflect that the marketing authorisation is no longer valid.

Arepanrix : EPAR - Summary for the public

English (EN) (185.59 KB - PDF)

**First published:** 26/04/2010

**Last updated:** 25/10/2011

[View](/en/documents/overview/arepanrix-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-860)

български (BG) (328.59 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/bg/documents/overview/arepanrix-epar-summary-public_bg.pdf)

español (ES) (248.24 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/es/documents/overview/arepanrix-epar-summary-public_es.pdf)

čeština (CS) (298.33 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/cs/documents/overview/arepanrix-epar-summary-public_cs.pdf)

dansk (DA) (188.06 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/da/documents/overview/arepanrix-epar-summary-public_da.pdf)

Deutsch (DE) (253.77 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/de/documents/overview/arepanrix-epar-summary-public_de.pdf)

eesti keel (ET) (185.92 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/et/documents/overview/arepanrix-epar-summary-public_et.pdf)

ελληνικά (EL) (338.72 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/el/documents/overview/arepanrix-epar-summary-public_el.pdf)

français (FR) (248.64 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/fr/documents/overview/arepanrix-epar-summary-public_fr.pdf)

italiano (IT) (190.62 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/it/documents/overview/arepanrix-epar-summary-public_it.pdf)

latviešu valoda (LV) (248.16 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/lv/documents/overview/arepanrix-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (224.88 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/lt/documents/overview/arepanrix-epar-summary-public_lt.pdf)

magyar (HU) (230.88 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/hu/documents/overview/arepanrix-epar-summary-public_hu.pdf)

Malti (MT) (255.64 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/mt/documents/overview/arepanrix-epar-summary-public_mt.pdf)

Nederlands (NL) (187.65 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/nl/documents/overview/arepanrix-epar-summary-public_nl.pdf)

polski (PL) (237.99 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/pl/documents/overview/arepanrix-epar-summary-public_pl.pdf)

português (PT) (190.5 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/pt/documents/overview/arepanrix-epar-summary-public_pt.pdf)

română (RO) (279.44 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/ro/documents/overview/arepanrix-epar-summary-public_ro.pdf)

slovenčina (SK) (294.07 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sk/documents/overview/arepanrix-epar-summary-public_sk.pdf)

slovenščina (SL) (225.9 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sl/documents/overview/arepanrix-epar-summary-public_sl.pdf)

Suomi (FI) (185.86 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/fi/documents/overview/arepanrix-epar-summary-public_fi.pdf)

svenska (SV) (186.4 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sv/documents/overview/arepanrix-epar-summary-public_sv.pdf)

## Product information

Arepanrix : EPAR - Product Information

English (EN) (517.87 KB - PDF)

**First published:** 26/04/2010

**Last updated:** 25/10/2011

[View](/en/documents/product-information/arepanrix-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-274)

български (BG) (1.55 MB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/bg/documents/product-information/arepanrix-epar-product-information_bg.pdf)

español (ES) (531.11 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/es/documents/product-information/arepanrix-epar-product-information_es.pdf)

čeština (CS) (1.64 MB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/cs/documents/product-information/arepanrix-epar-product-information_cs.pdf)

dansk (DA) (528.4 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/da/documents/product-information/arepanrix-epar-product-information_da.pdf)

Deutsch (DE) (538.44 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/de/documents/product-information/arepanrix-epar-product-information_de.pdf)

eesti keel (ET) (513.27 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/et/documents/product-information/arepanrix-epar-product-information_et.pdf)

ελληνικά (EL) (1.27 MB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/el/documents/product-information/arepanrix-epar-product-information_el.pdf)

français (FR) (536.49 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/fr/documents/product-information/arepanrix-epar-product-information_fr.pdf)

íslenska (IS) (265.1 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/is/documents/product-information/arepanrix-epar-product-information_is.pdf)

italiano (IT) (539.67 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/it/documents/product-information/arepanrix-epar-product-information_it.pdf)

latviešu valoda (LV) (928.16 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/lv/documents/product-information/arepanrix-epar-product-information_lv.pdf)

lietuvių kalba (LT) (621.94 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/lt/documents/product-information/arepanrix-epar-product-information_lt.pdf)

magyar (HU) (774.61 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/hu/documents/product-information/arepanrix-epar-product-information_hu.pdf)

Malti (MT) (870.6 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/mt/documents/product-information/arepanrix-epar-product-information_mt.pdf)

Nederlands (NL) (546.66 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/nl/documents/product-information/arepanrix-epar-product-information_nl.pdf)

norsk (NO) (252.33 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/no/documents/product-information/arepanrix-epar-product-information_no.pdf)

polski (PL) (891.91 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/pl/documents/product-information/arepanrix-epar-product-information_pl.pdf)

português (PT) (532.66 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/pt/documents/product-information/arepanrix-epar-product-information_pt.pdf)

română (RO) (642.61 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/ro/documents/product-information/arepanrix-epar-product-information_ro.pdf)

slovenčina (SK) (827.58 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sk/documents/product-information/arepanrix-epar-product-information_sk.pdf)

slovenščina (SL) (790.04 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sl/documents/product-information/arepanrix-epar-product-information_sl.pdf)

Suomi (FI) (523.69 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/fi/documents/product-information/arepanrix-epar-product-information_fi.pdf)

svenska (SV) (522.86 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sv/documents/product-information/arepanrix-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0005/G 13/08/2010

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Arepanrix : EPAR - All Authorised presentations

English (EN) (179.38 KB - PDF)

**First published:** 26/04/2010

**Last updated:** 25/10/2011

[View](/en/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-291)

български (BG) (233.78 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/bg/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_bg.pdf)

español (ES) (180.17 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/es/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_es.pdf)

čeština (CS) (219.96 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/cs/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (180.71 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/da/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (144.19 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/de/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (177.66 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/et/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (282.37 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/el/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_el.pdf)

français (FR) (177.06 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/fr/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (177.95 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/it/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (219.15 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/lv/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (213.97 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/lt/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (215.42 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/hu/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (226.25 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/mt/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (181.43 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/nl/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_nl.pdf)

polski (PL) (222.92 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/pl/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_pl.pdf)

português (PT) (179.81 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/pt/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_pt.pdf)

română (RO) (215.48 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/ro/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (222.2 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sk/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (148.75 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sl/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (178.84 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/fi/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (144.68 KB - PDF)

**First published:**

26/04/2010

**Last updated:**

25/10/2011

[View](/sv/documents/all-authorised-presentations/arepanrix-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Arepanrix Active substance split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs. International non-proprietary name (INN) or common name pandemic influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) Therapeutic area (MeSH)

- Influenza, Human
- Immunization
- Disease Outbreaks

Anatomical therapeutic chemical (ATC) code J07BB02

### Pharmacotherapeutic group

Influenza vaccines

### Therapeutic indication

Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance

## Authorisation details

EMA product number EMEA/H/C/001201

Conditional approval

This medicine received a conditional marketing authorisation. This was granted in the interest of public health because the medicine addresses an unmet medical need and the benefit of immediate availability outweighs the risk from less comprehensive data than normally required. For more information, see [Conditional marketing authorisation](/node/68774) .

Marketing authorisation holder

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89

Marketing authorisation issued 23/03/2010 Withdrawal of marketing authorisation 13/12/2010 Revision 1

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Arepanrix : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (165.16 KB - PDF)

**First published:** 25/10/2011

**Last updated:** 25/10/2011

[View](/en/documents/procedural-steps-after/arepanrix-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Arepanrix : EPAR - Public assessment report

Adopted

English (EN) (2.36 MB - PDF)

**First published:** 26/04/2010

**Last updated:** 25/10/2011

[View](/en/documents/assessment-report/arepanrix-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Arepanrix

Adopted

Reference Number: EMA/CHMP/30965/2010

English (EN) (52.26 KB - PDF)

**First published:** 22/01/2010

**Last updated:** 22/01/2010

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-arepanrix_en.pdf)

#### More information on Arepanrix

- [EMEA-000687-PIP01-09-M02 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000687-pip01-09-m02)
- [200405 - An observational retrospective database analysis to estimate the risk of Multiple Sclerosis (MS) following vaccination with Arepanrix™ in Manitoba, Canada - post-authorisation study](https://catalogues.ema.europa.eu/study/31668)

**This page was last updated on** 25/10/2011

## Share this page

[Back to top](#main-content)